Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-07-2022 | Erythropoietin | Case report

Epoetin-alfa

Pure red series aplasia: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Sepp TDS, et al. APLASIA PURA DE CELULAS VERMELHAS POR PROVAVEL ANTICORPO ANTIERITROPOETINA EM PACIENTE DE HEMODIALISE: RELATO DE CASO. Hematology, Transfusion and Cell Therapy 43 (Suppl. 1): S34-S35, Oct 2021. Available from: URL: http://doi.org/10.1016/j.htct.2021.10.059 [Portuguese; summarised from a translated abstract] Sepp TDS, et al. APLASIA PURA DE CELULAS VERMELHAS POR PROVAVEL ANTICORPO ANTIERITROPOETINA EM PACIENTE DE HEMODIALISE: RELATO DE CASO. Hematology, Transfusion and Cell Therapy 43 (Suppl. 1): S34-S35, Oct 2021. Available from: URL: http://​doi.​org/​10.​1016/​j.​htct.​2021.​10.​059 [Portuguese; summarised from a translated abstract]
Metadata
Title
Epoetin-alfa
Pure red series aplasia: case report
Publication date
01-07-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-18803-z

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Amiodarone

Case report

Iodine

Case report

Multiple drugs

Case report

Multiple drugs